已收盘 10-31 16:00:00 美东时间
0.000
0.00%
Business combination transaction completed with Forbion European Acquisition Corp. Clinical stage biotechnology company with EG-70 lead program in pivotal clinical study targeting BCG-unresp...
2023-11-01 19:30
BOSTON and MONTREAL, Sept. 7, 2023 /PRNewswire/ - enGene, Inc., a clinical-stage biotechnology company mainstreaming gene therapy through its novel platform for the delivery of therapeutics ...
2023-09-07 19:00
enGene, Inc. (“enGene”), a clinical-stage biotechnology company pioneering novel non-viral gene therapies for local administration into mucosal tissues, and Forbion European Acquisition Corp.
2023-05-17 19:22
Centiva Capital LP cut its holdings in Forbion European Acquisition Corp. (NASD...
2023-02-22 23:53